Company profile: Isolere Bio
1.1 - Company Overview
Company description
- Provider of biotherapeutic purification solutions, offering IsoTag Reagent Technology that combines phase separation with affinity ligands to purify biologics, IsoTag AAV for downstream purification of AAV serotypes, IsoTag LV for capturing and concentrating lentivirus, custom development of tailored purification solutions, and pipeline programs for adenovirus, mRNA, and pDNA purification.
Products and services
- IsoTag™ AAV: Affinity-based reagent for downstream purification of adeno-associated virus (AAV) serotypes, combining affinity capture with liquid-liquid phase separation
- IsoTag™ LV: TFF-compatible reagent for capturing and concentrating lentivirus from cell culture harvests, using low-speed centrifugation or tangential flow filtration
- IsoTag™ Reagent Technology: Phase-separation-based technology that combines phase separation with affinity ligands to purify biologics from contaminants in recombinant manufacturing processes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Isolere Bio
Synpromics
HQ: United Kingdom
Website
- Description: Provider of synthetic promoters to control gene expressions and regulations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synpromics company profile →
BBI Group
HQ: United Kingdom
Website
- Description: Provider of diagnostic products to multiple industries, founded on superior gold reagents. A trusted partner to leading diagnostic and healthcare organisations for over 25 years, with three businesses delivering excellence in diagnostic assay development and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BBI Group company profile →
Helmer Scientific
HQ: United States
Website
- Description: Provider of specialized medical and laboratory equipment, including GX Solutions medical-grade refrigerators and freezers for critical healthcare applications with temperature control, noise management, and energy efficiency; Pro Line platelet incubators with performance monitoring and advanced cooling; i.Series ultra-low temperature freezers; i.Series laboratory refrigerators/freezers; and blood bank refrigerators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Helmer Scientific company profile →
Axion Biosystems
HQ: United States
Website
- Description: Provider of multi-electrode array and impedance-based platforms for real-time, continuous, label-free cellular analysis, including monitoring of proliferation, viability, morphology, attachment, signaling, and immune cell-mediated killing. Offers single- and multi-well systems, high-throughput formats, automation modules, and integrated circuits to eliminate stimulation artifacts for research, clinical, and drug discovery markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Axion Biosystems company profile →
Accel Biotech
HQ: United States
Website
- Description: Provider of OEM robotic engines, liquid handling solutions, customized robotics, and components, manufacturing and distributing these offerings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accel Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Isolere Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Isolere Bio
2.2 - Growth funds investing in similar companies to Isolere Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Isolere Bio
4.2 - Public trading comparable groups for Isolere Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →